Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
33,331,988
-
Share change
-
-418,188
-
Total reported value
-
$650,146,662
-
Put/Call ratio
-
32%
-
Price per share
-
$19.50
-
Number of holders
-
101
-
Value change
-
-$11,846,583
-
Number of buys
-
61
-
Number of sells
-
45
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2022
As of 31 Dec 2022,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,331,988 shares.
The largest 10 holders included
NEA Management Company, LLC, Frazier Life Sciences Management, L.P., BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rock Springs Capital Management LP, STATE STREET CORP, Novo Holdings A/S, RiverVest Venture Management LLC, and CITADEL ADVISORS LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.